ACARIX.ST
Acarix AB (publ) [ACARIX.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ACARIX.ST Stock Summary
Top 10 Correlated ETFs
ACARIX.ST
Top 10 Correlated Stocks
ACARIX.ST
In the News
ACARIX.ST Financial details
Company Rating
-
Market Cap
201.99M
Income
-77.84M
Revenue
6.24M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
20
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
-1.16
Forward P/E
-
PEG
0.27
P/S
22.73
P/B
3.1
P/C
-
P/FCF
-1.87
Quick Ratio
0.99
Current Ratio
2.63
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.16
EPS next Y
-
EPS next Q
-
EPS this Y
-42.86%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-33.5%
Revenue last 5Y
27.43%
Revenue Q/Q
-25.37%
EPS Q/Q
-10.21%
-
-
-
-
SMA20
-12%
SMA50
-8.33%
SMA100
-29.03%
Inst Own
-
Inst Trans
-
ROA
-202%
ROE
-186%
ROC
-2.65%
Gross Margin
82%
Oper. Margin
-1214%
Profit Margin
-1227%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.175-0.580486
52W High
-
52W Low
-
RSI
40.72
Rel Volume
0.05
Avg Volume
4.18M
Volume
195.11K
Perf Week
-11.48%
Perf Month
-22.49%
Perf Quarter
-30.38%
Perf Half Y
-33.54%
-
-
-
-
Beta
1.377
-
-
Volatility
0.01%, 0.02%
Prev Close
0.47%
Price
0.212
Change
-0.93%
Company Profile
- Volume Average 4.18M
- Market Capitalization 201.99M
- Employee 20
- CEO Mr. Aamir Mahmood
- Headquarters Malmö,SE
- IPO Date 2016-12-19
-
Website
https://www.acarix.com 
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.
